Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Revenues	$ 2,267	$ 1,522
Cost of revenues	1,193	1,065
Impairment of inventory	368	0
Gross profit	706	457
Sales and marketing expenses	1,023	1,103
General and administrative expenses	3,363	3,854
Research and development costs	1,634	1,683
Operating Loss	(5,314)	(6,183)
Loss on extinguishment of debt	0	(6,006)
Gain from change in fair value of hybrid financial instruments	5,351	10,932
Gain (loss)from change in fair value of derivative liability - warrants	(12,223)	11,615
Gain from change in fair value of derivative liability - Series C and D preferred stock and debentures	15,715	26,949
Interest expense related to convertible debt	(4,378)	(2,217)
Net Income (loss)	(849)	35,090
Dividends on convertible preferred stock	0	(2,500)
Net Income (loss) available to common shareholders	(849)	32,590
Comprehensive income (loss):
Net income (loss)	(849)	35,090
Other comprehensive loss - foreign currency translation adjustment	(40)	(50)
Comprehensive Income (loss)	$ (889)	$ 35,040
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ 0	$ 1.44
Fully diluted (in dollars per share)	$ 0	$ (0.01)
Weighted average number of common shares:
Basic (in shares)	205,213,037	22,681,031
Fully diluted (in shares)	205,213,037	629,687,199